Data / Form D filings / Axxia Pharmaceuticals, LLC
Axxia Pharmaceuticals, LLC: Form D filings
Axxia Pharmaceuticals, LLC, a pharmaceuticals company in Bel Air, MD, filed 6 Form D notices with the SEC between 2011 and 2017. The latest, on February 2, 2017, reports an offering of $3 million with nothing sold yet.
Find out what Axxia Pharmaceuticals, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2614 WEST MEDICAL HALL ROAD, Bel Air, MD, 21015
- Phone
- (610) 255-4474
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Maryland
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1514545
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 2, 2017 | New notice | $3,000,000 | $0 | $3,000,000 | 0 | Yet to occur | sec.gov |
| Feb 14, 2013 | New notice | $300,000 | $0 | $300,000 | 0 | Yet to occur | sec.gov |
| Mar 12, 2012 | New notice | $800,000 | $300,000 | $500,000 | 1 | Mar 1, 2012 | sec.gov |
| Sep 23, 2011 | New notice | $350,000 | $0 | $350,000 | 0 | Yet to occur | sec.gov |
| Apr 1, 2011 | New notice | $100,000 | $100,000 | $0 | 8 | Mar 30, 2011 | sec.gov |
| Mar 4, 2011 | New notice | $150,000 | $150,000 | $0 | 9 | Feb 18, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Wally Phillip Grimm | Director | |
| Bernard Phillip Rudnick | Executive Officer, Director | |
| Sally Phillip MacConnell | Director | |
| D. Phillip Cox | Executive Officer, Director | |
| Stuart Phillip Grossman | Director | |
| Wayne Pollock | Executive Officer, Director | |
| David Phillip Wheatley | Director |
Every Form D from the week of Jan 30, 2017 · All recent filings in Maryland · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Axxia Pharmaceuticals, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.